Industry News

Columbia City medical-device maker to add up to 100 jobs
Smith & Nephew Launches Regranex360™ - a New Support Network for Patients Using REGRANEX® (becaplermin) Gel, 0.01%
GSK To Start Marketing First Malaria Vaccine In 2014
Teva Announces Quartette levonorgestrel/ethinyl estradiol and ethinyl estradiol Tablets Now Available for the Prevention of Pregnancy in the United... Teva Women's Health, Inc.
Pharmaceutical Research Company Plans To Create 320 Jobs At Facility In St. Charles, Gov. Nixon Announces
Test Demonstrates Effectiveness of Cancer Therapy in Children
Neurowave Medical Technologies™ Launches ReliefBand® Voyager: The #1 Trusted Name to Treat Motion Sickness
Precision Spine™ Plans to Introduce New Products at North American Spine Society Meeting in New Orleans
Precision Spine™ Plans to Introduce New Products at North American Spine Society Meeting in New Orleans
Neurowave Medical Technologies™ Launches ReliefBand® Voyager: The #1 Trusted Name to Treat Motion Sickness
CPhI Annual Expert Industry Report: Part I
Anacor Pharmaceuticals Announces FDA Acceptance of Tavaborole NDA for Filing
Pharmaceutical Research Company Plans To Create 320 Jobs At Facility In St. Charles, Gov. Nixon Announces
Test Demonstrates Effectiveness of Cancer Therapy in Children
Centers for Medicare & Medicaid Services Awards Three-Year Contract to Support Text4baby Implementation in Four States
FDA approves Clinolipid for intravenous nutrition; Action addresses shortages of drugs needed by patients unable to eat or drink
Pfizer Inc. Announces FDA Approval Of DUAVEETM (conjugated estrogens/ bazedoxifene) For The Treatment Of Moderate-To-Severe Vasomotor Symptoms (Hot Flashes) Associated With Menopause And The Prevention Of Postmenopausal Osteoporosis
Test Demonstrates Effectiveness of Cancer Therapy in Children
FDA approves first pre-surgical breast cancer drug
Medicare agency won't pay for Eli Lilly imaging drug for Alzheimer's diagnoses
Anacor Pharmaceuticals Announces FDA Acceptance of Tavaborole NDA for Filing
Bayer Introduces Kogenate FS Antihemophilic Factor (Recombinant) with Vial Adapter at 2013 NHF Meeting Vial Adapter offers Kogenate FS patients an additional choice in reconstitution systems
Anacor Pharmaceuticals Announces FDA Acceptance of Tavaborole NDA for Filing
Bayer Introduces Kogenate® FS Antihemophilic Factor (Recombinant) with Vial Adapter at 2013 NHF Meeting Vial Adapter offers Kogenate® FS patients an additional choice in reconstitution systems
Pharmaceutical Research Company Plans To Create 320 Jobs At Facility In St. Charles, Gov. Nixon Announces